Centro Medico San Francisco

Monterrey, Nuevo León 64710

0 studies enrolling now · 2 studies all time

What they study most

Dyslipidemia, Type 2 Diabetes, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes — Completed